Mizuho Securities USA’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.3M Buy
61,931
+14,026
+29% +$14.3M 1.2% 11
2026
Q1
$44.1M Sell
47,905
-9,918
-17% -$10.1M 1.04% 12
2025
Q4
$62.2M Sell
57,823
-81
-0.1% -$77.5K 1.03% 12
2025
Q3
$42.4M Buy
57,904
+3,539
+7% +$2.63M 0.86% 14
2025
Q2
$42.4M Sell
54,365
-8,725
-14% -$6.78M 0.9% 14
2025
Q1
$52.1M Sell
63,090
-11,588
-16% -$9.64M 1.12% 13
2024
Q4
$57.7M Buy
74,678
+23,525
+46% +$19.5M 1.05% 13
2024
Q3
$45.3M Sell
51,153
-10,407
-17% -$9.36M 0.97% 12
2024
Q2
$55.7M Buy
+61,560
New +$49.2M 1.23% 11
2020
Q3
Sell
-1,697
Closed -$279K 180
2020
Q2
$279K Buy
+1,697
New +$260K 0.02% 122
2019
Q2
Sell
-30,400
Closed -$3.94M 146
2019
Q1
$3.94M Buy
+30,400
New +$3.7M 0.3% 38

Other funds holding LLY

Mizuho Securities USA's LLY Position: Q2 2026 in Review

Mizuho Securities USA increased its Eli Lilly (LLY) stake by 29% in Q2 2026, buying an estimated $14.3M and bringing the position to 61,931 shares worth $74.3M. The position accounts for 1.2% of the portfolio, ranked #11.

Mizuho Securities USA first reported a position in LLY in Q1 2019 and has held it in 11 quarters since. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mizuho Securities USA held 61,931 shares of Eli Lilly worth $74.3M as of Q2 2026.
  • Mizuho Securities USA bought 14,026 Eli Lilly shares in Q2 2026, an estimated $14.3M.
  • Eli Lilly made up 1.2% of Mizuho Securities USA's portfolio in Q2 2026, its #11 holding.
  • Mizuho Securities USA first reported a position in Eli Lilly in Q1 2019 and has held it in 11 quarters since.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.